Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?(J Neurooncol, Doi:10.1007/s11060-015-2025-5)

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Access to Document

@article{455aaef8bf9f4037b53c5b125039a0e9,

title = "Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?(J Neurooncol, Doi:10.1007/s11060-015-2025-5)",

author = "Blumenthal, {D. T.} and L. Mendel and F. Bokstein",

year = "2016",

month = may,

day = "1",

doi = "10.1007/s11060-016-2100-6",

language = "אנגלית",

volume = "127",

pages = "503",

journal = "Journal of Neuro-Oncology",

issn = "0167-594X",

publisher = "Kluwer Academic Publishers",

number = "3",

}

TY - JOUR

T1 - Erratum to

T2 - The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?(J Neurooncol, Doi:10.1007/s11060-015-2025-5)

AU - Blumenthal, D. T.

AU - Mendel, L.

AU - Bokstein, F.

PY - 2016/5/1

Y1 - 2016/5/1

UR - http://www.scopus.com/inward/record.url?scp=84960109458&partnerID=8YFLogxK

U2 - 10.1007/s11060-016-2100-6

DO - 10.1007/s11060-016-2100-6

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:84960109458

SN - 0167-594X

VL - 127

SP - 503

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

IS - 3

ER -